Skip to content

Clinical trials

COVID-19 trials in Kazakhstan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: Kazakhstan Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20206
20216
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astana Medical University3
Karaganda Medical University3
Research Institute for Biological Safety Problems3
Asfendiyarov Kazakh National Medical University1
Catalysis SL1
National Research Center for Cardiac Surgery, Kazakhstan1
Scientific Center for Anti-infectious Drugs, Kazakhstan1
Semey State Medical University1
University Medical Center, Kazakhstan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1915
Coronavirus Infections3
Severe Acute Respiratory Syndrome3
Pneumonia2
Pneumonia, Viral2
Cognitive Dysfunction1
Coinfection1
Hypoxia1
Influenza, Human1
Noncommunicable Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.